Results 31 to 40 of about 167,455 (238)

Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke

open access: yesОбщая реаниматология, 2021
According to epidemiological studies, the leading cause of morbidity, disability and mortality are cerebrovascular diseases, in particular ischemic and hemorrhagic strokes.
A. M. Golubev   +5 more
doaj   +1 more source

Occurrence, Risk Factors, and Prognosis of Acute Cerebral Microinfarcts in CADASIL

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic cerebral small vessel disease in adults. This study investigates the occurrence, risk factors, and prognosis of acute cerebral microinfarcts (ACMIs) in patients with CADASIL.
Xuejiao Men   +11 more
wiley   +1 more source

Role of Von Willebrand factor level as a biomarker in acute ischemic stroke

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Background Von Willebrand factor (VWF) is a large, multimeric glycoprotein that plays a role in thrombus formation; it is also an important mediator of inflammation.
Asmaa Sayed Sabbah   +5 more
doaj   +1 more source

Anticoagulation initiation after non ⁃ valvular atrial fibrillation with acute ischemic stroke

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery
Anticoagulant treatment is an important strategy for secondary stroke prevention in non⁃valvular atrial fibrillation and acute ischemic stroke patients.
LU Feng⁃min, WU Dong⁃yan
doaj   +1 more source

Neuroimaging in Acute Schemic Stroke: Role and Recent Advances

open access: yes대한영상의학회지, 2019
Neuroimaging plays a key role in assessing the detection of acute hemorrhage, diagnosis of infarct core, detection of steno-occlusive arteries, mismatch between infarct core and penumbra, and collateral circulation in patients with acute cerebral ...
Se Jin Cho   +7 more
doaj   +1 more source

The concentration of homocysteine in patients after ischemic brain stroke and vascular dementia

open access: yesJournal of Health Sciences, 2011
Introduction: The aim of this study is to examine whether moderate hiperhomocysteinemia is an independent risk factor for cerebral infarction. Methods: We have measured homocysteine levels in 50 patients with ischemic stroke during acute phase and ...
Nafija Serdarević   +2 more
doaj   +1 more source

The Diagnostic Value of sTWEAK in Acute Ischemic Stroke

open access: yesBalkan Medical Journal, 2020
Background: Considering the critical role of early diagnosis and management of acute ischemic stroke, biomarkers that can reliable assist in the diagnosis are still needed.
Ertan Comertpay   +5 more
doaj   +1 more source

Serotonergic and Dopaminergic Function in Neuropsychiatrically Asymptomatic People With HIV on Antiretroviral Therapy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective People with HIV (PWH) on antiretroviral therapy (ART) still experience neurocognitive dysfunction and accelerated brain volume loss. To assess whether the serotonergic and dopaminergic systems are affected, we used [11C]DASB positron emission tomography (PET) to assess presynaptic serotonergic function and [18F]FDOPA PET to measure ...
Chuen‐Yen Lau   +12 more
wiley   +1 more source

Exploring the pivotal variables of tongue diagnosis between patients with acute ischemic stroke and health participants

open access: yesJournal of Traditional and Complementary Medicine, 2022
Background and aim: Stroke is a major cause of disability worldwide, and ischemic stroke is the most common type of stroke. The prevention and treatment of ischemic stroke remain a challenge worldwide.
Yung-Sheng Huang   +7 more
doaj  

Acute Ischemic Stroke Trials [PDF]

open access: yesStroke, 2001
To the Editor: We congratulate Duncan and colleagues on their illuminating report regarding outcome measures in acute stroke trials.1 However, we wish to point out that their claim to have analyzed all “phase II and phase III randomized trials of pharmacological interventions in the acute phase of stroke, published in English in 1980 or later” may be
David S Liebeskind   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy